Literature DB >> 452841

Serum phenytoin, phenobarbital, carbamazepine, albumin; and plasma estradiol, progesterone concentrations during the menstrual cycle in women with epilepsy.

T Bäckström, P Jorpes.   

Abstract

Six menstrual cycles and three 1-month periods were studied in seven patients with epilepsy. The patients all had had anti-epileptic treatment for a long time. In each case, the dosages had been costant for at least 1 month prior to the start of the investigation. Blood samples were taken every second day. Phenytoin, phenobarbital, carbamazepine, estradiol and pregesterone were analyzed. The serum levels of the anti-epileptic drugs were correlated to the plasma hormone concentrations. No correlations were obtained between the plasma hormone concentrations and the serum levels of the anti-epileptic drugs. There is, therefore, no evidence that the relationship between the seizure frequency and plasma hormone concentrations, shown in a previous study (Bäckström 1976)) was related to a change in serum levels of the anti-epileptic drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 452841     DOI: 10.1111/j.1600-0404.1979.tb02912.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  12 in total

1.  Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics.

Authors:  B Bruguerolle; M Toumi; F Faraj; D Vervloet; H Razzouk
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Variation of seizure frequency with ovulatory status of menstrual cycles.

Authors:  Andrew G Herzog; Kristen M Fowler; Michael R Sperling; Joyce D Liporace; Laura A Kalayjian; Christianne N Heck; Gregory L Krauss; Barbara A Dworetzky; Page B Pennell
Journal:  Epilepsia       Date:  2011-07-14       Impact factor: 5.864

3.  The effects of estrus cycle on drug metabolism in the rat.

Authors:  Y Brandstetter; J Kaplanski; V Leibson; Z Ben-Zvi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Oct-Dec       Impact factor: 2.441

Review 4.  Neuroendocrine considerations in the treatment of men and women with epilepsy.

Authors:  Cynthia L Harden; Page B Pennell
Journal:  Lancet Neurol       Date:  2013-01       Impact factor: 44.182

5.  Interictal spike frequency varies with ovarian cycle stage in a rat model of epilepsy.

Authors:  James D'Amour; Alejandra Magagna-Poveda; Jillian Moretto; Daniel Friedman; John J LaFrancois; Patrice Pearce; Andre A Fenton; Neil J MacLusky; Helen E Scharfman
Journal:  Exp Neurol       Date:  2015-04-10       Impact factor: 5.330

Review 6.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

7.  Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective.

Authors:  P Talwar; N Kanojia; S Mahendru; R Baghel; S Grover; G Arora; G K Grewal; S Parween; A Srivastava; M Singh; S Vig; S Kushwaha; S Sharma; K Bala; S Kukreti; R Kukreti
Journal:  Pharmacogenomics J       Date:  2016-03-08       Impact factor: 3.550

Review 8.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 9.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

10.  Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy.

Authors:  D Rościszewska; B Buntner; I Guz; L Zawisza
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.